Jing Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jing Xia has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Aik Choon Tan
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
6 shared publications Brittelle E. Kessler
6 shared publicationsKatie M. Mishall
6 shared publicationsKelsey E. Wuensch
6 shared publicationsMaia L. Corpuz
6 shared publications- Qiong Zhou
Jiyang College, Zhejiang A&F University, Zhuji, People’s Republic of China
6 shared publications
Latest Publications
- Open Access
Zearalenone Exposure Disrupts STAT-ISG15 in Rat Colon: A Potential Linkage between Zearalenone and Inflammatory Bowel Disease
Zearalenone (ZEN), a prevalent mycotoxin contaminating food and known for its intestinal toxicity, has been suggested as a potential risk factor for inflammatory bowel disease (IBD), although the exact relationship between ZEN exposure and IBD remains unclear. In this study, we established a rat model of colon toxicity induced by ZEN exposure to investigate the key targets of ZEN-induced colon toxicity and explore the underlying connection between ZEN exposure and IBD. Histological staining of the rat colon revealed significant pathological changes resulting from ZEN exposure (p < 0.01). Furthermore, the proteomic analysis demonstrated a notable upregulation of protein expression levels, specifically STAT2 (0.12 ± 0.0186), STAT6 (0.36 ± 0.0475) and ISG15 (0.43 ± 0.0226) in the rat colon (p < 0.05). Utilizing bioinformatics analysis, we combined ZEN exposure and IBD clinical sample databases to reveal that ZEN exposure may increase the risk of IBD through activation of the STAT-ISG15 pathway. This study identified novel targets for ZEN-induced intestinal toxicity, providing the basis for further study of ZEN exposure to IBD.
Open AccessZearalenone Exposure Disrupts STAT-ISG15 in Rat Colon: A Potential Linkage between Zearalenone and Inflammatory Bowel Disease
Zearalenone (ZEN), a prevalent mycotoxin contaminating food and known for its intestinal toxicity, has been suggested as a potential risk factor for inflammatory bowel disease (IBD), although the exact relationship between ZEN exposure and IBD remains unclear. In this study, we established a rat model of colon toxicity induced by ZEN exposure to investigate the key targets of ZEN-induced colon toxicity and explore the underlying connection between ZEN exposure and IBD. Histological staining of the rat colon revealed significant pathological changes resulting from ZEN exposure (p < 0.01). Furthermore, the proteomic analysis demonstrated a notable upregulation of protein expression levels, specifically STAT2 (0.12 ± 0.0186), STAT6 (0.36 ± 0.0475) and ISG15 (0.43 ± 0.0226) in the rat colon (p < 0.05). Utilizing bioinformatics analysis, we combined ZEN exposure and IBD clinical sample databases to reveal that ZEN exposure may increase the risk of IBD through activation of the STAT-ISG15 pathway. This study identified novel targets for ZEN-induced intestinal toxicity, providing the basis for further study of ZEN exposure to IBD.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S3. Increased co-immunoprecipitation of B-Raf and c-Raf upon 5μM treatment with dasatinib in thyroid cancer cell lines. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3. Increased co-immunoprecipitation of B-Raf and c-Raf upon 5μM treatment with dasatinib in thyroid cancer cell lines. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S6. Synergistic inhibition of thyroid cancer cell growth to dasatinib when combined with MEK 1/2 Inhibition. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6. Synergistic inhibition of thyroid cancer cell growth to dasatinib when combined with MEK 1/2 Inhibition. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S7. Prolonged inhibition of both Src and the MAP Kinase pathway results in a reduction in colony and tumor formation. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7. Prolonged inhibition of both Src and the MAP Kinase pathway results in a reduction in colony and tumor formation. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S1. Enrichment of the Melanoma pathway in the dasatinib-resistant cell lines. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
The Kegg pathway Melanoma was enriched (p-value: 0.1465), enriched in the DasRes cell lines. Portrayed are the genes in the melanoma pathway. Highlighted in dark grey are genes that are enriched in the dasatinib-resistant cell lines. Genes enriched include: PIK3R5, E2F3, IGF1R, PIK3CG, PDGFB, FGF7, FGF21, FGF22, BRAF, E2F1, FGF2, FGF14, FGF9, MAPK1, EGFR, PDGFC, FGF1, CCND1, MAP2K1.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1. Enrichment of the Melanoma pathway in the dasatinib-resistant cell lines. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
The Kegg pathway Melanoma was enriched (p-value: 0.1465), enriched in the DasRes cell lines. Portrayed are the genes in the melanoma pathway. Highlighted in dark grey are genes that are enriched in the dasatinib-resistant cell lines. Genes enriched include: PIK3R5, E2F3, IGF1R, PIK3CG, PDGFB, FGF7, FGF21, FGF22, BRAF, E2F1, FGF2, FGF14, FGF9, MAPK1, EGFR, PDGFC, FGF1, CCND1, MAP2K1.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Figure S5. Trametinib Overcomes Dasatinib Resistance in a Flank model of thyroid tumorigenesis. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
Tumor weights were measured upon euthanasia for both the Cal62 DasRes and Parental cell lines treated for 29 days with 1mg/kg QD trametinib. Data as means +/- SEM (n=8; student t-test; ***, P < 0.0005)
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5. Trametinib Overcomes Dasatinib Resistance in a Flank model of thyroid tumorigenesis. from The Mitogen-Activated Protein Kinase Pathway Facilitates Resistance to the Src Inhibitor Dasatinib in Thyroid Cancer
Tumor weights were measured upon euthanasia for both the Cal62 DasRes and Parental cell lines treated for 29 days with 1mg/kg QD trametinib. Data as means +/- SEM (n=8; student t-test; ***, P < 0.0005)
- Open Access
Universal quantum computation based on nanoscale skyrmion helicity qubits in frustrated magnets
Skyrmions in frustrated magnets have the helicity degree of freedom, where two different configurations of Bloch-type skyrmions are energetically favored by the magnetic dipole-dipole interaction and characterized by opposite helicities. A skyrmion must become a quantum-mechanical object when its radius is of the order of nanometer. We construct a qubit based on the two-fold degeneracy of the Bloch-type nanoscale skyrmions in frustrated magnets. It is shown that the universal quantum computation is possible based on nanoscale skyrmions in a multilayered system. We explicitly show how to construct the $\pi /4$ phase-shift gate, the Hadamard gate, and the CNOT gate. The one-qubit quantum gates are materialized by temporally controlling the electric field and the spin current. The two-qubit gate is materialized with the use of the Ising-type exchange coupling by controlling the distance between the skyrmion centers in two adjacent layers. The merit of the present mechanism is that an external magnetic field is not necessary. Our results may open a possible way toward universal quantum computations based on nanoscale topological spin textures.Open AccessUniversal quantum computation based on nanoscale skyrmion helicity qubits in frustrated magnets
Skyrmions in frustrated magnets have the helicity degree of freedom, where two different configurations of Bloch-type skyrmions are energetically favored by the magnetic dipole-dipole interaction and characterized by opposite helicities. A skyrmion must become a quantum-mechanical object when its radius is of the order of nanometer. We construct a qubit based on the two-fold degeneracy of the Bloch-type nanoscale skyrmions in frustrated magnets. It is shown that the universal quantum computation is possible based on nanoscale skyrmions in a multilayered system. We explicitly show how to construct the $\pi /4$ phase-shift gate, the Hadamard gate, and the CNOT gate. The one-qubit quantum gates are materialized by temporally controlling the electric field and the spin current. The two-qubit gate is materialized with the use of the Ising-type exchange coupling by controlling the distance between the skyrmion centers in two adjacent layers. The merit of the present mechanism is that an external magnetic field is not necessary. Our results may open a possible way toward universal quantum computations based on nanoscale topological spin textures. - Open Access
- 1 February 2021
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 17, 613-626
Berberine Suppresses Mice Depression Behaviors and Promotes Hippocampal Neurons Growth Through Regulating the miR-34b-5p/miR-470-5p/BDNF Axis
Background: Berberine has been found to inhibit the progression of depression disorder, but its specific mechanism is still unclear. MicroRNA (miRNA) is considered to play an important role in the progression of depression. However, it is unclear whether Berberine is involved in the regulation of depression progression through miRNA. Methods: The chronic unpredictable mild stress (CUMS) mice model was constructed. Mice depression behaviors were evaluated by sucrose preference test (SPT) and forced swim test (FST). Quantitative real-time PCR was employed to assess the expression of miR-34b-5p, miR-470-5p and brain-derived neurotrophic factor (BDNF). The protein expression of BDNF was examined using Western blot analysis. In addition, the viability and apoptosis of hippocampal neurons were determined using cell counting kit 8 assay, flow cytometry and TUNEL assay. The interaction between BDNF and miR-34b-5p or miR-470-5p was verified by dual-luciferase reporter assay and RNA immunoprecipitation assay. Results: Our data indicated that Berberine could inhibit CUMS mice depression behaviors and enhance hippocampal neurons growth by targeting miR-34b-5p and miR-470-5p. In addition, we found that BDNF was a target of miR-34b-5p and miR-470-5p. Overexpressed BDNF could reverse the regulation of miR-34b-5p and miR-470-5p on CUMS mice depression behaviors and hippocampal neurons growth. Furthermore, Berberine could promote BDNF expression to regulate CUMS mice depression behaviors and hippocampal neurons growth. Conclusion: Berberine might inhibit the progression of depression disorder by regulating the miR-34b-5p/miR-470-5p/BDNF axis.
- 1 February 2021
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 17, 613-626
Open AccessBerberine Suppresses Mice Depression Behaviors and Promotes Hippocampal Neurons Growth Through Regulating the miR-34b-5p/miR-470-5p/BDNF Axis
Background: Berberine has been found to inhibit the progression of depression disorder, but its specific mechanism is still unclear. MicroRNA (miRNA) is considered to play an important role in the progression of depression. However, it is unclear whether Berberine is involved in the regulation of depression progression through miRNA. Methods: The chronic unpredictable mild stress (CUMS) mice model was constructed. Mice depression behaviors were evaluated by sucrose preference test (SPT) and forced swim test (FST). Quantitative real-time PCR was employed to assess the expression of miR-34b-5p, miR-470-5p and brain-derived neurotrophic factor (BDNF). The protein expression of BDNF was examined using Western blot analysis. In addition, the viability and apoptosis of hippocampal neurons were determined using cell counting kit 8 assay, flow cytometry and TUNEL assay. The interaction between BDNF and miR-34b-5p or miR-470-5p was verified by dual-luciferase reporter assay and RNA immunoprecipitation assay. Results: Our data indicated that Berberine could inhibit CUMS mice depression behaviors and enhance hippocampal neurons growth by targeting miR-34b-5p and miR-470-5p. In addition, we found that BDNF was a target of miR-34b-5p and miR-470-5p. Overexpressed BDNF could reverse the regulation of miR-34b-5p and miR-470-5p on CUMS mice depression behaviors and hippocampal neurons growth. Furthermore, Berberine could promote BDNF expression to regulate CUMS mice depression behaviors and hippocampal neurons growth. Conclusion: Berberine might inhibit the progression of depression disorder by regulating the miR-34b-5p/miR-470-5p/BDNF axis.